Connect with us

Bloomberg Technology

BioAge Labs Raises $170m to Develop Therapies Using AI

BioAge Labs, a clinical-stage biotechnology company developing therapies for obesity and metabolic disease thanks to their AI-powered discovery platform, raised $170 million in an oversubscribed series D financing round led by Sofinnova Investments. Kristen Fortney, BioAge CEO and Co-Founder, joins Ed Ludlow and Caroline Hyde on “Bloomberg Technology.” ——– Like this video? Subscribe to Bloomberg…

Published

on

BioAge Labs, a clinical-stage biotechnology company developing therapies for obesity and metabolic disease thanks to their AI-powered discovery platform, raised $170 million in an oversubscribed series D financing round led by Sofinnova Investments. Kristen Fortney, BioAge CEO and Co-Founder, joins Ed Ludlow and Caroline Hyde on “Bloomberg Technology.”
——–
Like this video? Subscribe to Bloomberg Technology on YouTube:

Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:

Get the latest in tech from Silicon Valley and around the world here:

Connect with us on…
Twitter:
Facebook:
Instagram:

Continue Reading
Advertisement
2 Comments

2 Comments

  1. @ponokealii

    February 13, 2024 at 3:05 pm

    We already have the answers to solving the problem of our imposed accelerated aging process and the devastating and life threatening potential of disease.

    We KNOW that our human genome has been artificially edited and manipulated to shorten our lifespan – limiting our naturally unlimited lifespan to just 120 years –

    We suspect that this genome manipulation was done by one of our progenitors, most likely the Annunaki.

    The evidence is readily apparent by looking at the second and third genomes in the human genome sequence which have been artificially fused together.

    This is not part of a natural evolutionary process but clearly an example of deliberate artificial gene manipulation.

    We now possess the ability to manipulate our own human genome far beyond what is being made publicly known.

    The answers to extending our lifetime to theoretical infinity and to ending disease is in our own hands.

    Immortality and perfect health are perfectly attainable.

    We have all the tools necessary and understand the methods and processes to edit the human genome for the benefit of all humanity.

    We only need the wisdom, foresight and courage to do what must be done.

    Ponokeali’i

Leave a Reply

Your email address will not be published. Required fields are marked *

Bloomberg Technology

Paramount and Skydance Revive Deal, Apple and OpenAI’s Relationship Deepens | Bloomberg Technology

Bloomberg’s Caroline Hyde breaks down the news that Paramount and Skydance reached a merger agreement after collapsing last month. Plus, Apple and OpenAI deepen their relationship as the iPhone maker gets an observer role on the AI company’s board. ——– “Bloomberg Technology” is our daily news program focused exclusively on technology, innovation and the future…

Published

on

Bloomberg’s Caroline Hyde breaks down the news that Paramount and Skydance reached a merger agreement after collapsing last month. Plus, Apple and OpenAI deepen their relationship as the iPhone maker gets an observer role on the AI company’s board.
——–
“Bloomberg Technology” is our daily news program focused exclusively on technology, innovation and the future of business hosted by Ed Ludlow from San Francisco and Caroline Hyde in New York.

Like this video? Subscribe and turn on the notifications for Bloomberg Technology on YouTube:

Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:

Get the latest in tech from Silicon Valley and around the world here:

Follow Ed Ludlow on Twitter here:
Follow Caroline Hyde on Twitter here:

Connect with us on…
Twitter:
Facebook:
Instagram:

Continue Reading

Bloomberg Technology

Sanofi CEO on AI’s Impact, Lung Disease Drug Clearance

Sanofi CEO Paul Hudson joins Caroline Hyde to discuss the company’s integration of AI tools in everyday operations, the impact of AI on the biopharma sector, and the company’s Dupixent drug getting cleared for a chronic lung disorder in the European Union, creating another avenue of growth for the blockbuster drug. He speaks on “Bloomberg…

Published

on

Sanofi CEO Paul Hudson joins Caroline Hyde to discuss the company’s integration of AI tools in everyday operations, the impact of AI on the biopharma sector, and the company’s Dupixent drug getting cleared for a chronic lung disorder in the European Union, creating another avenue of growth for the blockbuster drug. He speaks on “Bloomberg Technology.”
——–
Like this video? Subscribe to Bloomberg Technology on YouTube:

 
Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:

 
Get the latest in tech from Silicon Valley and around the world here:

Connect with us on…
X:
Facebook:
Instagram:
 
Follow Ed Ludlow on X here:
Follow Caroline Hyde on X here:
 
Listen to the daily Bloomberg Technology podcast here:

 
More from Bloomberg Business
Connect with us on…
X:
Facebook:
Instagram:
LinkedIn:
TikTok:

Continue Reading

Bloomberg Technology

Apple Set to Get OpenAI Board Observer Role

Apple will get an observer role on OpenAI’s board as part of a landmark agreement announced last month, further tightening ties between the once-unlikely partners. Bloomberg’s Mark Gurman joins Caroline Hyde on “Bloomberg Technology.” ——– Like this video? Subscribe to Bloomberg Technology on YouTube:   Watch the latest full episodes of “Bloomberg Technology” with Caroline…

Published

on

Apple will get an observer role on OpenAI’s board as part of a landmark agreement announced last month, further tightening ties between the once-unlikely partners. Bloomberg’s Mark Gurman joins Caroline Hyde on “Bloomberg Technology.”
——–
Like this video? Subscribe to Bloomberg Technology on YouTube:

 
Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:

 
Get the latest in tech from Silicon Valley and around the world here:

Connect with us on…
X:
Facebook:
Instagram:
 
Follow Ed Ludlow on X here:
Follow Caroline Hyde on X here:
 
Listen to the daily Bloomberg Technology podcast here:

 
More from Bloomberg Business
Connect with us on…
X:
Facebook:
Instagram:
LinkedIn:
TikTok:

Continue Reading

Trending